Deep Science Ventures’ Post

It's great to be there and meet all the start-ups, investors and corporations. I expect great ideas and lots of innovations in the life sciences. There is so much potential, we just need to tap into it! And thanks to all the start-ups 💎 who applied - they make an event like this a glimpse into the future. 🔮 #lifesciences #startups #pitching #biotechnology #labtechnology #investors

🎉 Exciting News: Catalera BioSolutions Secures Series A Funding! 🚀 We're thrilled to announce the initial close of our Series A funding round for Catalera BioSolutions, a groundbreaking spin-off from Terramera, launched just this May. 💰 Funding Highlights: • Round led by @S2G Ventures • Follow-up investment from @Farm Credit Canada (FCC) Capital • Final close expected in Q4 2024 🌱 Our Why: Synthetics can take us no further. Biologicals are the future. At Catalera, we're bridging the gap between nature and the needs of growers, homeowners and professionals. With over a decade of experience in developing safe, effective and affordable products, we are unleashing the full potential of biological ingredients in natural, safe formulation. 💬 From our CEO, @Matthew Dahabieh: "The world is ready for biologicals. As an agile and experienced company, Catalera holds the key to unlocking their potential. Our track record of successful product launches with leading partners, coupled with our exciting pipeline of innovations, positions us to make a significant impact in the industry." 🔬 What's Next: This funding will accelerate our product development and market entry, bringing sustainable solutions to growers, consumers, and industry leaders worldwide. 📄 Read the full press release: https://lnkd.in/gGRhDctK #AgTech #Sustainability #SeriesA #Biologicals #Innovation

We are excited to announce the first close of Forbion BioEconomy Fund I at €75 million. This new fund, led by Alexander Hoffmann and Joy Faucher, focuses on biotech-enabled solutions in #Food, #Agriculture, #Materials, and #Environmental #Technologies. The Forbion BioEconomy Fund aims to transform industries reliant on non-renewable resources by investing in sustainable, scalable, and cost-effective alternatives. Our team is supported by industry veterans Feike Sijbesma, ex-CEO of DSM, Cees de Jong, Chairman of Novonesis, Onno van de Stolpe, ex-CEO of Galapagos, and Stefan Oschmann, ex-CEO of Merck KGaA as Advisors and Venture Partners. This fund is a strategic expansion, leveraging our biotech expertise to address pressing planetary challenges. Join us as we drive innovations that will help clean and feed the planet. Click on the following link to learn more: https://lnkd.in/eumrYSSF #VentureCapital #Biotech #Sustainability #Forbion #BioEconomy

Hot off the back of CSIRO’s latest SynBio Roadmap, we’re taking a closer look at how Main Sequence’s investment in the space is translating into real-world application. 🧑🔬 We support over a dozen startups deeply rooted in SynBio, who, since 2021, have raised over $100m and created over 130 jobs. This includes the likes of Number 8 bio, creating carbon-neutral food products for agriculture, Nourish Ingredients, building animal-free fats to make plant-based food tastier and Psylo, leveraging inspiration from natural psychedelics to create next-gen therapeutics to treat mental illness. 🐄 🍄 Many of these companies are making their way into our lives in very big ways through partnerships with the likes of lululemon (Samsara Eco), Quicksilver (Uluu) and Norco Co-operative Limited (Eden Brew), translating research into real-world value. We’re proud to play a role in supporting what has the potential to be one of Australia’s major industries and are continuing to invest in and build incredible companies in the space. If you’re interested in learning more, reach out to Gabrielle Munzer or Jason Whitfield. 👋 #SyntheticBiology #SynBio

From An Underdog To Innovator, Your Time Is Now! #innovation #motivation #biotech #lifescience #innovation #motivation #underdogtoinnovator #successstories #lifetransformation #entrepreneurlife #inspirechange #bethechange #innovatorsmindset #overcomeobstacles #dreambig #startuplife #motivationalvideo #achievermore #changemaker

Few moments feel as good as watching our founders crush it out in the world. Seeing Harshal Chokhawala speak at SynBioBeta about building ZymoChem was one of those times. Our job as investors is to support the entrepreneurs who are ready to change the world. At Breakout Ventures, this means partnering with creative bioscience founders who are determined to overcome the biggest challenges in human and climate health. When Harshal launched ZymoChem to develop bio-based versions of chemicals and materials, he knew the height of the challenge he was taking on. Over the last few years, we’ve seen him grow his team, scale his tech, win strategic partnerships, and gain crucial funding to keep climbing. He’s taken the stage time and again to show the world how biomanufacturing will help us reach a fossil-free future. SynBioBeta reminds us that we are surrounded by people who believe in biotech's potential for solving our planet’s most pressing problems. Playing a role in this community of scientists and innovators is one of the highlights of my work. And - it was awesome to end the week on a enthusiastic and fun panel packed with folks fighting to make the future of synbio bright Taehong Huh (GS Futures),Kelsey Weimer (Synonym), Kristen McCarthy Barton, CFA (Mango Materials), and Richard Kenny (Hawkwood Biotech Partners). You can read more about ZymoChem’s success and how founders can follow in Harshal’s footsteps in our recent Medium article: https://lnkd.in/ggUiiv9k #SynBioBeta2024 #Biomanufacturing #ClimateTech #Biotech #SyntheticBiology #IndustrialBiotech

Forbion is pleased to announce its second BioEconomy fund investment in just two days, co-leading an oversubscribed €17.4m Series A financing round for NOVAMEAT, alongside Sofinnova Partners and existing investors Unovis Asset Management, Praesidium and Rubio Impact Ventures. This funding will enable Novameat to scale its production capacity through its proprietary MicroForce technology, further driving the development of sustainable plant-based meat alternatives. Alexander Hoffmann, General Partner at Forbion, will join the Novameat Board of Directors, while Joy Faucher, Partner at Forbion, will be appointed as Board Observer. This investment underscores our commitment to advancing biotech innovations that address urgent planetary health challenges. #VentureCapital #Impact #SustainableInnovation #BioEconomy #PlantBased #FutureOfFood #PlanetaryHealth #ESG #VC #lifesciences #biotech Click on the following link to read more: https://lnkd.in/ebAZw3XS

We are pleased to announce that via our Forbion BioEconomy fund strategy, we have led the oversubscribed $14m Series A financing of SOLASTA Bio, a pioneering agri-biotech company focused on sustainable crop protection solutions. Forbion’s BioEconomy fund invests in biotech companies that address critical planetary health challenges. The funds will be used to advance SOLASTA Bio’s nature-inspired bioinsecticides, with market entry anticipated in 2027—achieving this milestone in half the time typically required for synthetically produced alternatives. This demonstrates the strength and efficiency of SOLASTA Bio’s platform technology. As part of this partnership, Joy Faucher, Partner at Forbion, will join SOLASTA Bio’s Board of Directors, with Alexander Hoffmann, General Partner at Forbion, appointed as Board Observer.” #biotech #sustainability #planetaryhealth #impact #agriculture Click on the following link to read more: https://lnkd.in/eVPEK6cW

There are 100 ways to fix the future and Allozymes is one of them 💪 Norrsken has just dropped their Impact/100 2024 - an annual list of 100 companies that can positively impact the lives of 1 billion people. "It’s not just ideas - it’s 100 ways to fix the future. And behind all of these companies are people working daily to leave a positive mark on the planet. We believe they deserve all the recognition in the world." We're grateful and honored to be a part of it, and of course, ecstatic to see our brand up on Times Square 🗽 See the full list in the comments below! 👇 #Allozymes #Biotechnology #Biosolutions

„Growing fast, with a laser focus to market, Insempra might become the success story the synbio community needs right now.“ Thank you SynBioBeta, and John Cumbers for this great feature on our recent Series A funding round. 👉 Read the full article by clicking the link below